Please login to the form below

Not currently logged in
Email:
Password:

genomes

This page shows the latest genomes news and features for those working in and with pharma, biotech and healthcare.

Horizon Discovery and C4X to harness CRISPR for new cancer drugs

Horizon Discovery and C4X to harness CRISPR for new cancer drugs

Jon Moore. “Drugging the cancer genome now requires new synthetic lethal therapies that can exploit the vulnerabilities in patient's tumours that are created by mutations in undruggable cancer driver gene,”

Latest news

More from news
Approximately 8 fully matching, plus 135 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    The agreement is for the development of therapies to eliminate the hepatits B virus (HBV) in vivo using the genome editing platform ARCUS.  Development will be shared, with Precision responsible for

  • The critical role of science in healthcare communications The critical role of science in healthcare communications

    Entirely new fields of medicine are emerging, such as human genomics and precision therapies that are tailor-made for the individual based on specific genome sequencing.

  • Can new data aggregators shift the balance of power away from pharma? Can new data aggregators shift the balance of power away from pharma?

    However, it was only 20 years ago that several genomics companies, led by Human Genome Sciences Inc, thought they could secure a monopoly position over unprecedented drug targets by filing patents ... on gene sequences emerging from their own human

  • 30 Women Leaders in UK Healthcare 30 Women Leaders in UK Healthcare

    100, 000 Genomes Project. ... It represents the world’s largest depository of whole genomes with associated clinical data, and is already being used to diagnose and personalise treatment for people with rare diseases and cancers.

  • Integrating digital biomarkers into precision medicine Integrating digital biomarkers into precision medicine

    In many ways, this model parallels traditional biomarker development where, for example, blood samples can be collected early in clinical research to then support genome-wide association studies to detect genetic

More from intelligence
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 15 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics